Danielle M. Campbell

Danielle M. Campbell is a Clinical Assistant Professor in the Department of Preventive and Social Medicine at Charles R. Drew University of Medicine and Science. Her academic work focuses on advancing HIV cure research with particular attention to inclusion of women and marginalized populations in clinical trials.

Dr. Campbell's research interests span HIV cure research, health disparities, women's health, health equity, and bioethics in clinical research. She has made significant contributions to understanding how to improve inclusion of women, racial/ethnic minorities, and sexual and gender diverse populations in HIV cure-related research. Her work examines analytical treatment interruptions, participant perspectives, ethical considerations, and strategies to enhance diversity in clinical trials. A distinctive feature of her research is the centering of community voices in HIV cure research, particularly those of women who have been historically underrepresented in this field.

Analysis of Dr. Campbell's publication record from 2020-2022 reveals a strong focus on HIV cure research with particular emphasis on inclusion of underrepresented populations. Her work spans multiple domains including clinical trials methodology, ethical considerations, public health approaches, and patient perspectives. A notable trend is her dedication to addressing gender disparities in HIV research and ensuring women's perspectives are centered in cure-related studies, as evidenced by her leadership in the AIDS Clinical Trials Group 5366 study which focused exclusively on women's experiences in HIV cure research.

Dr. Campbell's collaborative network includes prominent HIV researchers across multiple institutions, with frequent co-authorship with experts in HIV cure research, bioethics, and public health. Her publications appear in high-impact journals including the Journal of Acquired Immune Deficiency Syndromes, BMC Public Health, and AIDS Research and Human Retroviruses.

Dr. Campbell is actively engaged in addressing critical gaps in HIV cure research through:

• Advocating for improved women's inclusion in clinical trials
• Developing ethical frameworks for analytical treatment interruptions
• Examining health disparities in HIV research participation
• Creating community-centered approaches to HIV cure research
• Exploring innovative methods for participant engagement

Her work demonstrates a commitment to translating research findings into practical strategies that enhance equity and inclusivity in the pursuit of an HIV cure, bridging the gap between clinical research and community health needs.